Biogen
BIIB
776 hedge funds and large institutions have $66.1B invested in Biogen in 2014 Q1 according to their latest regulatory filings, with 95 funds opening new positions, 284 increasing their positions, 294 reducing their positions, and 46 closing their positions.
107% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 46
9% more capital invested
Capital invested by funds: $60.8B → $66.1B (+$5.24B)
5% more funds holding
Funds holding: 738 → 776 (+38)
3% less repeat investments, than reductions
Existing positions increased: 284 | Existing positions reduced: 294
11% less funds holding in top 10
Funds holding in top 10: 37 → 33 (-4)
26% less call options, than puts
Call options by funds: $893M | Put options by funds: $1.2B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$257M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$167M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$158M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$149M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$136M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$672M |
| 2 |
JP Morgan Chase
New York
|
-$218M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$195M |
| 4 |
State Street
Boston,
Massachusetts
|
-$193M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$169M |
BIIB Hedge Fund Activity: Q1 2014 in Review
776 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q1 2014, worth a combined $66.1B — up 8.6% from $60.8B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new BIIB positions and 46 closed out — a net gain of 49 holders — while 284 added to existing stakes and 294 trimmed.
The largest buyer was Janus Henderson Investors US, adding an estimated $257M. The largest seller was Fidelity Investments, cutting an estimated $672M.
- 776 institutional investors held Biogen (BIIB) as of Q1 2014, up from 738 in Q4 2013.
- Funds reported $66.1B of Biogen stock for Q1 2014, up 8.6% quarter-over-quarter.
- 95 funds opened new Biogen positions in Q1 2014 and 46 closed out, a net change of +49 holders.
- The largest Biogen buyer in Q1 2014 was Janus Henderson Investors US, an estimated $257M added.
- The largest Biogen seller in Q1 2014 was Fidelity Investments, an estimated $672M sold.
Based on aggregated 13F filings for Q1 2014.